
Survival and Time to Initiation of Adjuvant Chemotherapy Among Breast Cancer Patients in Uruguay
Author(s) -
Cecilia Castillo,
Natalia Camejo,
Monika Rondan,
Florencia Savio,
Guadalupe Herrera,
Gabriel Krygier,
Lucı́a Delgado
Publication year - 2021
Publication title -
breast cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.19
H-Index - 27
ISSN - 1179-1314
DOI - 10.2147/bctt.s338276
Subject(s) - medicine , hazard ratio , breast cancer , chemotherapy , surgical oncology , proportional hazards model , stage (stratigraphy) , surgery , retrospective cohort study , adjuvant , adjuvant chemotherapy , cancer , confidence interval , oncology , paleontology , biology
Increases in disease-free survival and overall survival (OS) with the use of adjuvant chemotherapy in early breast cancer (BC) are widely known; however, the optimal time to initiate treatment with adjuvant chemotherapy remains controversial.